• Novel Zn-Fe/biochar catalyst enables 96% tetracycline and 100% rhodamine B degradation. • Surface charge modulation achieves pollutant-specific adsorption-degradation synergy. • 99% antibiotic removal in real wastewater without pH adjustment. • Radical and non-radical pathway synergy lowers toxicity of degradation intermediates. A bimetallic Zn-Fe/biochar composite catalyst was developed using walnut shell biochar as a support for Zn-Fe-containing surface species synthesized via reverse microemulsion. Its performance and mechanism in degrading tetracycline (TC) and rhodamine B (RhB) via peroxodisulfate (PDS) activation were systematically evaluated and compared to the traditional Fenton method. Characterization revealed positively charged Zn-Fe-containing surface species, contributing to electrostatic adsorption of anionic TC while biochar maintained affinity for cationic RhB. The composite exhibited high surface area and pore volume, facilitating mass transfer. Zn-Fe/biochar can efficiently activate PDS, generating hydroxyl radicals as important active species, and synergistically interacting with singlet oxygen generated through non-radical pathways. This achieved 96% TC and 100% RhB removal within 60 min, with degradation intermediates showing 40–70% reduced toxicity. Compared to Fenton, the system demonstrated wider pH adaptability (effective at pH 6.46–7.87 without adjustment), higher contaminant removal (>99% TC in pharmaceutical wastewater), lower metal leaching (Fe <20.8 μg·L -1 , Zn <3.7 μg·L -1 after five cycles), minimal secondary pollution (no iron sludge), and excellent COD reduction (residual COD of 56 mg·L -1 in pharmaceutical and 59 mg·L -1 in aquaculture wastewater). This work establishes Zn-Fe/biochar as a dual-functional and sustainable catalyst derived from biowaste. It offers a strategy not only for efficient recalcitrant pollutant removal via charge-directed synergy but also for concurrent phosphate adsorption, outperforming Fenton in efficiency, stability, and environmental safety while contributing to biomass valorization.
Guo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: